Coherus Oncology, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Wahlstrom Mats | — | Sale | 99,988 | $0.74 | $73,991 | May 23, 2025 |
| McMichael Bryan J | Chief Financial Officer | Tax Withholding | 1,711 | $1.39 | $2,378 | Jan 20, 2025 |
| Reider Paul | Chief Commercial Officer | Tax Withholding | 4,858 | $1.39 | $6,753 | Jan 20, 2025 |
| Lanfear Dennis M | President & CEO | Tax Withholding | 11,810 | $1.39 | $16,416 | Jan 20, 2025 |
| McMichael Bryan J | Chief Financial Officer | Tax Withholding | 1,711 | $1.57 | $2,686 | Jan 7, 2025 |
| Lanfear Dennis M | President & CEO | Tax Withholding | 11,810 | $1.66 | $19,605 | Jan 4, 2025 |
| Reider Paul | Chief Commercial Officer | Tax Withholding | 2,277 | $1.66 | $3,780 | Jan 4, 2025 |
| Reider Paul | Chief Commercial Officer | Tax Withholding | 2,073 | $1.61 | $3,338 | Dec 13, 2024 |
| Wahlstrom Mats | — | Gift | 99,988 | — | — | Feb 9, 2024 |
| Wahlstrom Mats | — | Option Exercise | 44,991 | $1.67 | $75,135 | Feb 1, 2024 |
| Lanfear Dennis M | President & CEO | Tax Withholding | 11,218 | $2.44 | $27,372 | Jan 20, 2024 |
| Reider Paul | Chief Commercial Officer | Tax Withholding | 4,854 | $2.44 | $11,844 | Jan 20, 2024 |
| McMichael Bryan J | See Remarks | Tax Withholding | 1,707 | $2.44 | $4,165 | Jan 20, 2024 |
| McMichael Bryan J | See Remarks | Tax Withholding | 1,707 | $2.87 | $4,899 | Jan 7, 2024 |
| Lanfear Dennis M | President & CEO | Tax Withholding | 11,781 | $2.92 | $34,401 | Jan 4, 2024 |
| Reider Paul | Chief Commercial Officer | Tax Withholding | 2,275 | $2.92 | $6,643 | Jan 4, 2024 |
| Stilwell McDavid | Chief Financial Officer | Tax Withholding | 18,440 | $3.33 | $61,405 | Dec 31, 2023 |
| Reider Paul | Chief Commercial Officer | Tax Withholding | 2,049 | $2.37 | $4,856 | Dec 13, 2023 |
| Lanfear Dennis M | President & CEO | Option Exercise | 258,940 | $1.42 | $367,695 | Nov 22, 2023 |
| Reider Paul | Chief Commercial Officer | Tax Withholding | 2,451 | $6.84 | $16,765 | Apr 1, 2023 |
| Stilwell McDavid | Chief Financial Officer | Tax Withholding | 3,457 | $6.84 | $23,646 | Apr 1, 2023 |
| Vexler Vladimir | Chief Scientific Officer | Tax Withholding | 16,278 | $6.84 | $111,342 | Mar 31, 2023 |
| Lanfear Dennis M | President & CEO | Award / Grant | 86,250 | — | — | Jan 20, 2023 |
| McMichael Bryan J | See Remarks | Award / Grant | 12,500 | — | — | Jan 20, 2023 |
| Vexler Vladimir | Chief Scientific Officer | Award / Grant | 40,000 | — | — | Jan 20, 2023 |
| Stilwell McDavid | Chief Financial Officer | Award / Grant | 40,000 | — | — | Jan 20, 2023 |
| Vexler Vladimir | Chief Scientific Officer | Tax Withholding | 3,602 | $9.85 | $35,480 | Jan 11, 2023 |
| McMichael Bryan J | See Remarks | Tax Withholding | 1,699 | $9.58 | $16,276 | Jan 7, 2023 |
| Lanfear Dennis M | President & CEO | Tax Withholding | 10,905 | $9.87 | $107,632 | Jan 4, 2023 |
| Vexler Vladimir | Chief Scientific Officer | Tax Withholding | 5,437 | $9.87 | $53,663 | Jan 4, 2023 |
| Stilwell McDavid | Chief Financial Officer | Tax Withholding | 5,437 | $9.87 | $53,663 | Jan 4, 2023 |
| Lanfear Dennis M | President & CEO | Gift | 4,000 | — | — | Dec 30, 2022 |
| Stilwell McDavid | Chief Financial Officer | Tax Withholding | 3,458 | $12.85 | $44,435 | Apr 1, 2022 |
| Vexler Vladimir | Chief Scientific Officer | Tax Withholding | 3,458 | $12.85 | $44,435 | Apr 1, 2022 |
| Wahlstrom Mats | — | Award / Grant | 29,994 | $2.08 | $62,388 | Feb 25, 2022 |
| Vexler Vladimir | Chief Scientific Officer | Tax Withholding | 4,150 | $14.30 | $59,345 | Jan 11, 2022 |
| Lanfear Dennis M | President & CEO | Award / Grant | 86,250 | — | — | Jan 4, 2022 |
| Stilwell McDavid | Chief Financial Officer | Award / Grant | 40,000 | — | — | Jan 4, 2022 |
| Vexler Vladimir | Chief Scientific Officer | Award / Grant | 40,000 | — | — | Jan 4, 2022 |
| Lanfear Dennis M | President & CEO | Gift | 10,000 | — | — | Nov 17, 2021 |
| Stilwell McDavid | Chief Financial Officer | Sale | 3,507 | $16.80 | $58,918 | Oct 15, 2021 |
| HEALY JAMES | — | Sale | 100,150 | $18.06 | $1,808,709 | Sep 28, 2021 |
| Anicetti Vincent R | Chief Operating Officer | Award / Grant | 50,000 | — | — | Jul 6, 2021 |
| Stilwell McDavid | Chief Financial Officer | Purchase | 3,700 | $13.42 | $49,654 | Jun 9, 2021 |
| Lanfear Dennis M | President & CEO | Option Exercise | 31,054 | $0.42 | $13,043 | Jun 6, 2021 |
| Anicetti Vincent R | Chief Operating Officer | Award / Grant | 20,000 | — | — | Apr 28, 2021 |
| Stilwell McDavid | Chief Financial Officer | Award / Grant | 20,000 | — | — | Apr 28, 2021 |
| Vexler Vladimir | Chief Scientific Officer | Award / Grant | 20,000 | — | — | Apr 28, 2021 |
| Vexler Vladimir | Chief Scientific Officer | Option Exercise | 20,312 | $9.30 | $188,902 | Mar 9, 2021 |
| Anicetti Vincent R | Chief Operating Officer | Option Exercise | 20,312 | $9.30 | $188,902 | Mar 5, 2021 |